• Home
  • About Journal
    Journal Introduction
    Editorial Board
    Youth Editorial Board
    Cooperating Institutions
    Editorial Department
  • Submission Guidelines
  • Policies & Statements
    Ethical Guidelines for Publication
    Academic Misconduct Statement
    Open Access (OA) Statement
    AIGC Use Statement
  • Journal Subscription
  • Download Center
  • 中文版
Cite this article:
ZHANG Juan,WEI Xia,WANG Haiping,LI Shuixian,GENG Xue,ZHAO Yan,ZHU Qingfen.Study on the antioxidant effect of Gubenmingmu Granule on D-galactose induced cataract in rats[J].Journal Of Pharmaceutical Research,2023,42(7):453-456,494[Click to copy]
【Print this page】      【Download PDF Full Text】   【View/Add Comment】  【Download reader】  【 Close 】
←Previous|Next→ Archive    Advanced Search
This article has been viewed: 2878times   Download 2930次 QR Code for this article
Scan with your phone!
固本明目颗粒对D-半乳糖性白内障模型大鼠抗氧化作用的研究
张娟1,魏霞1,王海苹2,李水仙1,耿雪1,赵岩1,祝清芬1
Font:Larger+|Default|Smaller-
(1.山东省食品药品检验研究院,国家药品监督管理局仿制药研究与评价重点实验室,山东 济南 250101;2.金诃藏药<山东>健康产业有限公司,山东 济南 250101)
摘要:
目的 研究固本明目颗粒1和固本明目颗粒2预防给药对D-半乳糖性白内障的抗氧化作用及固本明目颗粒工艺改变前后作用的差别。方法 取20日龄SD大鼠90只,雄性,试验随机分为9组,分别为空白对照组、模型对照组、阳性对照组、固本明目颗粒1和2 均设 1.25、2.5、5 g•kg-1.BW三个剂量组,每组10只。采用D-半乳糖建立大鼠的糖性白内障模型,各剂量组灌胃给予相应剂量的药物溶液10 mL•kg-1.BW,每天1次,连续21d,观察各组大鼠晶状体浑浊程度,末次给药后检测各组大鼠晶状体内SOD、GSH、GST、GSH-Px、Na+-K+-ATP酶活性情况,以及各组大鼠晶状体组织病理学改变。结果 与模型对照组比较,固本明目颗粒1低剂量组GSH、中剂量组SOD、高剂量组GST明显升高(P<0.05);固本明目颗粒2中、高剂量组GSH、中剂量组SOD明显升高(P<0.05或P<0.01)。阳性对照组、固本明目颗粒1各剂量组和固本明目颗粒2各剂量组晶状体混浊程度均有明显缓解效果。结论 固本明目颗粒1和固本明目颗粒2在1.25、2.5、5 g•kg-1.BW剂量下对D-半乳糖性白内障有一定的抗氧化作用,固本明目颗粒制备工艺改变前后抗氧化作用未见明显变化。
关键词:  固本明目颗粒  白内障  D-半乳糖  晶状体  过氧化损伤
DOI:10.13506/j.cnki.jpr.2023.07.004
基金项目:
Publication Date:July 25, 2023
Study on the antioxidant effect of Gubenmingmu Granule on D-galactose induced cataract in rats
ZHANG Juan1,WEI Xia1,WANG Haiping2,LI Shuixian1,GENG Xue1,ZHAO Yan1,ZHU Qingfen1
(1.Shandong Institute for Food and Drug Control, NMPA Key Laboratory for Research and Evaluation of Generic Drugs Jinan 250101, China;2.Jinhe Tibetan Medicine (Shandong) Health Industry Co., Ltd., Jinan 250100, China)
Abstract:
Objective To investigate the antioxidant effect of Gubenmingmu Granule 1 and Gubenmingmu Granule 2 on D-galactose cataract prevention and the difference of the effect before and after the change of the process of Gubenmingmu Granule. Methods Ninety 20-day-old SD rats (male) were randomly divided into 9 groups with 10 rats in each group, including blank control group, model control group, positive control group, Gubenmingmu Granules 1 1.25, 2.5, 5 g•kg-1.BW groups, Gubenmingmu Granules 2 1.25, 2.5, 5 g•kg-1.BW groups, respectively. D-galactose was used to establish the rat model of sugar cataract. Each dose group was given the corresponding dose of 10 mL•kg-1.BW drug solution by intragastrium, once a day, for consecutive 21d, the opacity of the lenses of rats in each group was observed, and the activities of SOD, GSH, GST, GSH-Px and Na+-K+ -ATPase in the lenses of rats in each group were detected after the last administration, as well as the histopathological changes of the lenses of rats in each group. Results Compared with model control group, GSH in low dose group, SOD in medium dose group and GST in high dose group of Gubenmingmu Granules 1 were significantly increased (P < 0.05). In Gubenmingmu Granules 2, GSH and SOD in medium and high dose groups were significantly increased (P < 0.05 or P < 0.01). The positive control group, Gubenmingmu Granules 1 dose groups and Gubenmingmu granules 2 dose groups all had obvious relief effect on the degree of lens opacity. Conclusion Gubenmingmu Granules 1 and 2 had certain antioxidant effects on D-galactose cataract at doses of 1.25, 2.5 and 5 g•kg-1.BW, and no significant changes were observed in antioxidant effects of Gubenmingmu granules before and after the change of preparation technology.
Key words:  Guben Mingmu Granule  Cataract  D-galactose  Lens  Peroxide damage
Today's Visits:483    Total Visits:2383194
Website copyright:Editorial Board of Journal of Pharmaceutical Research     鲁ICP备17018036号-3     鲁公网安备 37010202001351号
Sponsored by:Shandong Institute for Food and Drug Control Shandong Pharmaceutical Association Address:No.2749 Xinluo Street,High-Tech Zone,Jinan,P.R.China Postcode:250101
Telephone Number:0531-81216586 Email :yaoxueyanjiu@163.com;yaoxueyanjiu@126.com
Technical Support:Beijing Qinyun Technology Co., Ltd.